drugset / Trial / NCT00344175
Follow-on Protocol of Pitavastatin Versus Simvastatin in Patients With Hypercholesterolemia or Dyslipidemia and Coronary Heart Disease Risk Factors
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a sixteen-week follow-on and 28 week single-blind extension study for patients who participated in study NK-104-304.
Timeline
- Start
- 2006-06
- Primary completion
- 2007-08
- Completion
- 2007-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pitavastatin | Small molecule | 4 mg | — |
| Comparator | Simvastatin | Small molecule | 40 mg | — |
| Comparator | Simvastatin | Small molecule | 80 mg | — |